The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
NCRI 2018 | The gut microbiome: role in causing and detecting colorectal cancer
Speaking from the 2018 National Cancer Research Institute (NCRI) Cancer Conference, held in Glasgow, UK, Paul O’Toole, PhD, from the University College Cork, Cork, Ireland, discusses the role of the gut microbiome as a promising and targetable risk factor for colorectal cancer (CRC). Prof. O’Toole not only highlights the microbial community within the gut as a potential diagnostic tool for CRC, but also as a modifiable modulator of cancer immunotherapy.
